Bing Li
73Patents
12h-index
213Co-inventors
87Inventor score
Filing activity: Aug 2, 1996 → Jan 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8552002B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 77 | Active |
| US7642255B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 53 | Active |
| US6057428A | Variants of vascular endothelial cell growth factor | Physics | 39 | Expired |
| US10326166B2 | Gel electrolytes and precursors thereof | Emerging Cross-Sectional Technologies | 28 | Active |
| US8247415B2 | Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists | Chemistry; Metallurgy | 28 | Active |
| US8399480B2 | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists | Chemistry; Metallurgy | 23 | Active |
| US7371750B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 21 | Expired |
| US7411955B2 | 3-layer VPN and constructing method thereof | Electricity | 20 | Expired |
| US8076517B2 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | Chemistry; Metallurgy | 17 | Active |
| US7405221B2 | Substituted pyrimidines | Chemistry; Metallurgy | 17 | Expired |
| US8653260B2 | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists | Chemistry; Metallurgy | 16 | Active |
| US8354403B2 | Pyrrolidine derived beta 3 adrenergic receptor agonists | Chemistry; Metallurgy | 12 | Active |
| US7951400B2 | Coated tablet formulation and method | Human Necessities | 9 | Active |
| US9040679B2 | Methods and compositions for extraction and storage of nucleic acids | Chemistry; Metallurgy | 7 | Active |
| US9044738B2 | Methods and compositions for extraction and storage of nucleic acids | Physics | 7 | Active |
| US9534214B2 | Substrates and associated methods for elution of nucleic acids | Chemistry; Metallurgy | 7 | Active |
| US9480966B2 | Substrates and methods for collection, stabilization and elution of biomolecules | Chemistry; Metallurgy | 7 | Active |
| US9290517B2 | Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives | Human Necessities | 6 | Active |
| US7338957B2 | Compounds and compositions as protein kinase inhibitors | Human Necessities | 6 | Expired |
| US9540364B2 | Benzimidazole tetrahydrofuran derivatives | Chemistry; Metallurgy | 5 | Active |
| US8796258B2 | Cyclic azabenzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 5 | Active |
| US9527839B2 | Benzimidazole tetrahydropyran derivatives | Chemistry; Metallurgy | 5 | Active |
| US9556193B2 | Benzimidazole hexahydrofuro[3,2-b]furan derivatives | Human Necessities | 4 | Active |
| US9868733B2 | Azabenzimidazole tetrahydrofuran derivatives | Chemistry; Metallurgy | 4 | Active |
| US7090834B1 | Vascular endothelial cell growth factor variants and uses thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.